SCHEMBL4450178

SCHEMBL4450178

N#Cc1ccc(-c2ccccc2)c(-c2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.59
ALDH1A1 P00352 1/20 0.51
MAPT P10636 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
PTGDR2 Q9Y5Y4 3/20 0.46
PTPN5 P54829 2/20 0.46
KDM1A O60341 1/20 0.46
PSEN1 P49768 1/20 0.46
PSEN2 P49810 1/20 0.46
APH1B Q8WW43 1/20 0.46
NCSTN Q92542 1/20 0.46
APH1A Q96BI3 1/20 0.46
PSENEN Q9NZ42 1/20 0.46
BACE1 P56817 2/20 0.43
PDK2 Q15119 3/20 0.43
TOP1 P11387 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4450175 0.85 KIF11 (0.75) KIF11ALDH1A1MAPTSMN1; SMN2TDP1
SCHEMBL31741945 0.85 PTGDR2 (0.50) ALDH1A1PTGDR2PDK2
SCHEMBL996126 0.85 PTGDR2 (0.50) ALDH1A1PTGDR2PDK2
SCHEMBL31741946 0.85 PTGDR2 (0.50) ALDH1A1PTGDR2PDK2
SCHEMBL3422472 0.85 PTGDR2 (0.53) PTGDR2PDK2
SCHEMBL20740894 0.81 PTGDR2 (0.50) PTGDR2PDK2
SCHEMBL9952009 0.79 KIF11 (0.61) KIF11ALDH1A1MAPTSMN1; SMN2TDP1
SCHEMBL2371259 0.79 AR (0.47) KIF11ALDH1A1PTGDR2PDK2
SCHEMBL29914875 0.78 AR (0.46) KIF11ALDH1A1PTGDR2PDK2
SCHEMBL21046587 0.78 AR (0.46) KIF11ALDH1A1PTGDR2PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7507830-B2 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles PHARMACORE, INC. (US) 2009-03-24 US disclosed
US-6962999-B2 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles PHARMACORE, INC. (US) 2005-11-08 US disclosed
US-20050124808-A1 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles DSM I.P. ASSETS B.V. (NL) 2005-06-09 US disclosed
US-20030100760-A1 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles DSM N.V. (NL) 2003-05-29 US disclosed
EP-1279656-A2 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles DSM N.V. (NL) 2003-01-29 EP disclosed
US-6194599-B1 Process for preparing biaryl compounds CATALYTICA, INC. 2001-02-27 US disclosed
US-5922898-A Process for preparing biaryl compounds CATALYTICA PHARMACEUTICALS, INC. (US) 1999-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030100760-A1 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles AHR, PAH, DDT KIF11 2492/4885ALDH1A1 3227/4885MAPT 4353/4885
US-20050124808-A1 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles AHR, PAH, DDT KIF11 2492/4885ALDH1A1 3227/4885MAPT 4353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.